Subhi Marwari

TL;DR: In this article, using 16S ribosomal RNA (rRNA) gene sequencing, the microbial compositions of 165 subjects with MDD are compared with 217 BD, and 217 healthy controls (HCs).

TL;DR: A review of the recent progress in the understanding of Relaxin Family Peptides and their Receptors is presented in this article, where the authors draw attention to the current preclinical evidence available that suggests the relevance of the NI/relaxin-3 system to the pathology and/or symptoms of certain neuropsychiatric disorders and to provide cognizant directions for future research to effectively and efficiently uncover its therapeutic potential.

TL;DR: The results suggest that (R)-fluoxetine, which has been reported to have a shorter half-life than (S)- fluoxettine, has superior antidepressant effects and more consistently improves spatial learning and memory.

TL;DR: It is concluded that stapling of the relaxin3 B chain does not compromise its ability to activate RXFP3 and is a promising method for developing stable peptide agonists and antagonists of RX FP3 to aid relaxin-3/RXFP3 research.

TL;DR: It is proposed that a hydrocarbon‐stapled mimetic of relaxin‐3, when administered intranasally, might be uniquely applicable to the treatment of these disorders.